Explore 3 Stock Ideas & Industry Insights Download Free Report

ACS Global Inc

Healthcare US AMCY

NoneUSD
0.00(0%)

Last update at 2024-09-26T03:06:13.231453Z

Day Range

--
LowHigh

52 Week Range

3.005.00
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown
Breakdown
Breakdown

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
AMCY
ACS Global Inc
- -% - - - - -
TMO
Thermo Fisher Scientific Inc
-0.6 0.13% 464.01 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation
1.02 0.58% 178.19 29.09 28.01 5.67 3.20 6.00 19.09
A
Agilent Technologies Inc
-0.57 0.45% 126.49 34.36 26.39 6.59 7.14 6.78 23.56
IDXX
IDEXX Laboratories Inc
-16.36 2.91% 545.73 49.99 45.66 11.29 27.85 11.46 34.46

Reports Covered

Stock Research & News

Profile

ACS Global, Inc. engages in the collection, processing, and long-term storage of stem cells. The company's services would allow individuals to privately preserve their stem cells for potential future use in cell therapy. The company was formerly known as American CryoStem Corp. and changed its name to ACS Global, Inc. in June 2011. The company is based in Red Bank, New Jersey.

ACS Global Inc

188 East Bergen Place, Red Bank, NJ, United States, 07701

Key Executives

Name Title Year Born
Mr. Anthony Francis Dudzinski Jr. Pres, Director & Treasurer 1963
Mr. John S. Arnone Director & Sec. 1958

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions